Abstract
Migraine is a destabilizing neuroinflammatory disorder characterized by recurrent headache attacks. Evidences show tumor necrosis factor (TNF)-α play a role in neuroimmunity pathogenesis of migraine. TNF-α increase prostanoid production, hyperexcitability of neurons, and nociceptor activation resulted in neuroinflammation and neurogenic pain. ω-3 fatty acids and curcumin exert neuroprotective and anti-inflammatory effects via several mechanisms including suppression of TNF-α gene expression and its serum levels. The aim of this study is an evaluation of synergistic effects of ω-3 fatty acids and nano-curcumin on TNF-α gene expression and serum levels in migraine patients. The present study performed as a clinical trial over a 2 month period included 74 episodic migraine patients in 4 groups and received ω-3 fatty acids, nano-curcumin, and combination of them or placebo. At the start and the end of the study, the gene expression of TNF-α and TNF-α serum levels was measured by real-time PCR and ELISA method, respectively. Our results showed that the combination of ω-3 fatty acids and nano-curcumin downregulated TNF-α messenger RNA (mRNA) significantly in a synergistic manner (P < 0.05). As relative to gene expression, a significant greater reduction in serum levels of TNF-α were observed in the combination group, but no significant differences in other groups. Supplementation with ω-3 fatty acids or nano-curcumin alone did not show significant reduction either in mRNA or serum levels of TNF-α. In addition, a much greater reduction in attack frequency was found in the combination group (P < 0.001). These findings indicated that ω-3 fatty acids and curcumin supplementation can be considered as a new promising approach in migraine management.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00251-017-0992-8/MediaObjects/251_2017_992_Fig1_HTML.gif)
Similar content being viewed by others
References
Bauer I, Crewther S, Pipingas A, Sellick L, Crewther D (2014) Does omega-3 fatty acid supplementation enhance neural efficiency? A review of the literature Human Psychopharmacology: Clinical and Experimental 29:8–18
Bazan NG, Molina MF, Gordon WC (2011) Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration Alzheimer's, and other neurodegenerative diseases. Annual Review of Nutrition 31:321–351
Boćkowski L, Śmigielska-Kuzia J, Sobaniec W, Żelazowska-Rutkowska B, Kułak W, Sendrowski K (2010) Anti-inflammatory plasma cytokines in children and adolescents with migraine headaches. Pharmacological Reports 62:287–291
Chen M et al (2015) Tumor necrosis factor (TNF)–308G> A, nitric oxide synthase 3 (NOS3)+ 894G> T polymorphisms and migraine risk: a meta-analysis. PLoS One 10:e0129372
Covelli V et al (1991a) Increased spontaneous release of tumor necrosis factor-α/cachectin in headache patients. A possible correlation with plasma endotoxin and hypothalamic-pituitary-adrenal axis. International journal of neuroscience 61:53–60
Covelli V et al (1991b) In vivo administration of propranolol decreases exaggerated amounts of serum TNF-alpha in patients with migraine without aura. Possible mechanism of action. Acta neurologica 14:313–319
Cunha F, Poole S, Lorenzetti B, Ferreira S (1992) The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia. British journal of pharmacology 107:660–664
de Alcântara GFT et al (2017) Curcumin reverses neurochemical, histological and immuno-histochemical alterations in the model of global brain ischemia. Journal of Traditional and Complementary Medicine 7:14–23
Deverman BE, Patterson PH (2009) Cytokines and CNS development. Neuron 64:61–78
Fidan I, Yüksel S, Ýmir T, İrkeç C, Aksakal FN (2006) The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 171:184–188
Franceschini A, Vilotti S, Ferrari MD, Van Den Maagdenberg AM, Nistri A, Fabbretti E (2013) TNFα levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraine. PloS one 8:e52394
Ganjali S et al (2014) Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial. The Scientific World Journal:2014
Garza I, Swanson JW (2006) Prophylaxis of migraine. Neuropsychiatric disease and treatment 2:281
Gerring ZF, Powell JE, Montgomery GW, Nyholt DR (2017) Genome-wide analysis of blood gene expression in migraine implicates immune-inflammatory pathways Cephalalgia:0333102416686769
Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as “curecumin”: from kitchen to clinic. Biochem Pharmacol 75:787–809
Harel Z, Gascon G, Riggs S, Vaz R, Brown W, Exil G (2002) Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. Journal of Adolescent Health 31:154–161
Haut SR, Bigal ME, Lipton RB (2006) Chronic disorders with episodic manifestations: focus on epilepsy and migraine. The Lancet Neurology 5:148–157
Ji R-R, Xu Z-Z, Strichartz G, Serhan CN (2011) Emerging roles of resolvins in the resolution of inflammation and pain. Trends in Neurosciences 34:599–609
Jia Q et al (2011) Dietary fish oil and curcumin combine to modulate colonic cytokinetics and gene expression in dextran sodium sulphate-treated mice. British journal of nutrition 106:519–529
Kanai M et al (2012) Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer chemotherapy and pharmacology 69:65–70
Levy D (2010) Migraine pain and nociceptor activation—where do we stand? Headache: The Journal of Head and Face Pain 50:909–916
Liu R et al (2014) Effects of tumor necrosis factor-β (TNF-β) 252A> G polymorphism on the development of migraine: a meta-analysis. PLoS One 9:e100189
Longoni M, Ferrarese C (2006) Inflammation and excitotoxicity: role in migraine pathogenesis. Neurological Sciences 27:s107–s110
Malhotra R (2016) Understanding migraine: Potential role of neurogenic inflammation. Annals of Indian Academy of Neurology 19:175
Mirza M et al (2013) Progressive retinal degeneration and glial activation in the CLN6 nclf mouse model of neuronal ceroid Lipofuscinosis: a beneficial effect of DHA and curcumin supplementation. PLoS One 8:e75963
Mittal N, Joshi R, Hota D, Chakrabarti A (2009) Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat. Phytotherapy Research 23:507–512
Mottaghi A, Salehi E, Keshvarz A, Sezavar H, Saboor-Yaraghi A-A (2013) The influence of vitamin A supplementation on Foxp3 and TGF-β gene expression in atherosclerotic patients. Journal of nutrigenetics and nutrigenomics 5:314–326
Mueller L, Gupta AK, Stein TP (2001) Deficiency of tumor necrosis factor α in a subclass of menstrual migraineurs Headache. The Journal of Head and Face Pain 41:129–137
Mulder EJ et al (2003) Genetic and environmental influences on migraine: a twin study across six countries. Twin Research 6:422–431
Perini F et al (2005) Plasma cytokine levels in migraineurs and controls Headache. The Journal of Head and Face Pain 45:926–931
Pietrobon D, Moskowitz MA (2013) Pathophysiology of migraine. Annual review of physiology 75:365–391
Pradalier A, Bakouche P, Baudesson G, Delage A, Cornaille-Lafage G, Launay J, Biason P (2001) Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: a double-blind study versus placebo. Cephalalgia 21:818–822
Ramirez-Ramirez V et al. (2013) Efficacy of fish oil on serum of TNFα, IL-1β, and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b. Oxidative medicine and cellular longevity 2013
Sasaki H et al (2011) Innovative preparation of curcumin for improved oral bioavailability. Biological and Pharmaceutical Bulletin 34:660–665
Saw CLL, Huang Y, Kong A-N (2010) Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: docosahexaenoic acid or eicosapentaenoic acid. Biochemical pharmacology 79:421–430
Shehzad A, Lee Y (2010) Curcumin: multiple molecular targets mediate multiple pharmacological actions: a review. Drugs Fut 35:113
Shehzad A, Rehman G, Lee YS (2013) Curcumin in inflammatory diseases. Biofactors 39:69–77
Shishodia S (2013) Molecular mechanisms of curcumin action: gene expression. Biofactors 39:37–55
Stovner L et al (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27:193–210
Tajmirriahi M, Sohelipour M, Basiri K, Shaygannejad V, Ghorbani A, Saadatnia M (2012) The effects of sodium valproate with fish oil supplementation or alone in migraine prevention: A randomized single-blind clinical trial. Iranian Journal of Neurology 11:21
Tanure MTA, Gomez RS, Hurtado RCL, Teixeira AL, Domingues RB (2010) Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study. The journal of headache and pain 11:427–430
Thota RN, Acharya SH, Abbott KA, Garg ML (2016) Curcumin and long-chain omega-3 polyunsaturated fatty acids for prevention of type 2 diabetes (COP-D): study protocol for a randomised controlled trial. Trials 17:565
Ward TN (2012) Migraine diagnosis and pathophysiology . CONTINUUM. Lifelong Learning in Neurology 18:753–763
Xu Z-Z et al (2010) Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med 16:592–597
Yu S et al (2012) The prevalence and burden of primary headaches in China: a population-based door-to-door survey Headache. The Journal of Head and Face Pain 52:582–591
Acknowledgments
This study was approved by ethics committee of the Tehran University Medical of Sciences (TUMS). Those who participated in this study are kindly acknowledged.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Abdolahi, M., Tafakhori, A., Togha, M. et al. The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients. Immunogenetics 69, 371–378 (2017). https://doi.org/10.1007/s00251-017-0992-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00251-017-0992-8